Nervonik raises $52.5M to enhance peripheral nerve stimulation system

Nervonik, a peripheral nerve stimulation device developer, closed a $52.5 million Series B funding round led by Amzak Health. The oversubscribed round included participation from Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, and Shangbay Capital. The capital will support enhancement of the company's nerve stimulation platform.